FindTrial
Sign In

Role of homoeopathic medicines on immunity in leprosy

Role of homoeopathic medicines in up-regulation of host immunity using leprosy disease model

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2008/091/000080
Enrollment
180
Registered
2008-11-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Mercurius solubilis ,Sulphur,Natrum Muraticum: 200 potency for one year Intervention2: Multi Drug Therapy (Rifampicin, Dapson,Clofamazine): WHO recomended dose and schedule Control Inte

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Proven cases of ladult male and female eprosy patient between the age group from 18 to 60 years who have had no previous history of treatment will be taken in the study.

Exclusion criteria

Exclusion criteria: Patients having any history of previous treatment by MDT, having blood sugar and HIV infection will not be included in the study. Patient above 60 years and below 18 years of age will be excluded from the study .

Design outcomes

Primary

MeasureTime frame
In vitro assays of interleukins (IFNy, TNFa,IL-4, IL-10 ) in the peripheral blood , 10. Estimation of interlieukins like IFNy, TNFa IL2, IL4, IL10 of M. leprae antigen stimulated PBMC at different stagesTimepoint: two years—

Secondary

MeasureTime frame
Complete regain of sensation,regain of normal skin colour, regain of normalcy from psychological depressionTimepoint: Three years—

Countries

India

Contacts

Public ContactDr.Tuhin Chakraborty
drtuhinchakraborty@gmail.com033 23344950

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026